Tag: Philips
Philips continues to lean on international sleep growth, as FDA path continues
May 8, 2026Liz Beaulieu, Editor
AMSTERDAM – The Sleep and Respiratory Care (SRC) business at Philips grew in the low single digits in the first quarter of 2026, but its obstructive sleep apnea (OSA) portfolio stood out with double-digit growth outside of the U.S., says CEO Roy Jakobs.
International markets fuel OSA growth
OSA growth was particularly strong in Japan, the company’s second-largest market, Jakobs said during a recent conference call to discuss the company’s financial results.
“If you...
Philips delivers ‘good start to 2026,’ CEO says
May 6, 2026HME News Staff
AMSTERDAM – Philips reported group sales of EUR 3.9 billion for the first quarter of 2026, a 4% increase compared to the same period last year. Sales for Connected Care, which includes the Sleep and Respiratory Care segment, increased 3%.
Other financial results:
Comparable order intake growth 6%
Income from operations increased to EUR 241 million
Adjusted EBITA margin increased 40 basis points to 9.0%
Operating cash flow of EUR 188 million, with free cash flow of EUR 28 million
“We...
In brief: Coral ‘getting started,’ Access Infusion expanding, Medline piloting automation
April 22, 2026HME News Staff
NEW YORK – Coral, a health care automation platform built for durable medical equipment (DME) and other specialty providers, has announced a $12.5 million investment led by Lightspeed and Z47 to grow its team and enhance its products.
The platform connects to existing EHR systems, fax lines and payer portals and automates end-to-end administrative workflows.
“Every person in the health care system is being slowed down by the same thing: administrative work that was never built to...
Philips issues correction for Trilogy Evo Platform ventilators
April 20, 2026HME News Staff
AMSTERDAN – Philips has issued a correction for Trilogy Evo Platform Ventilators, according to the U.S. Food and Drug Administration (FDA). The company has identified issues related to the use of prohibited non-pneumatic nebulizers and the obstruction alarm timing. As of March 6, it has reported three serious injuries and no deaths associated with these issues. Philips has sent affected customers a letter recommending that they:
Update all Trilogy Evo Platform ventilators with software...
In brief: AAH’s call to action, DreamStation’s new designation, CMS’s new ABN
March 20, 2026HME News Staff
WASHINGTON – AAHomecare is urging providers to build support for the DIABETES Act (S. 4037), which, among other things, would delay Medicare competitive bidding for continuous glucose monitors (CGMs) and insulin pumps for five years.
The bill, which was introduced March 12 by Sens. Jeanne Shaheen, D-N.H., and Susan Collins, R-Maine, would also expand Medicare coverage of diabetes self-management training sessions.
AAHomecare says stakeholders can build important early support for this...
Philips DreamStation receives medically necessary designation for certain patients
March 19, 2026HME News Staff
ANDOVER, Mass. – Philips has announced that DreamStation BiPAP AVAPS devices have been designated as medical necessary for lower-weight patients with breathing impairment. The devices, which include S, T, S/T, and PC modes with AVAPS, are available for sale in the United States for new setups for patients with obstructive sleep apnea (OSA) and respiratory impairment, who are both >7 years of age and weighing 40-66 pounds. “Patient safety is at the...
Philips targets innovation, trust
February 11, 2026Liz Beaulieu, Editor
AMSTERDAM – In a key post-recall milestone, Philips says it has more than doubled its number of 510(k) clearances from the U.S. Food and Drug Administration (FDA) over the past two years.
During a recent conference call to discuss fourth quarter and full-year financial results, Roy Jakobs reiterated that Philips continues “to address the consequences of the Respironics recall” and “relentlessly work toward resolution of the FDA warning letter issued...
Philips navigates U.S. trade investigation with tariff mitigation, strategic investments
November 7, 2025Liz Beaulieu, Editor
AMSTERDAM – Royal Philips is controlling what it can in response to a U.S. investigation into the potential national security risks associated with imported medical equipment and other tariff-related threats, says Roy Jakobs.
A previous investigation under Section 232 of the Trade Expansion Act of 1962 resulted in higher tariffs for the steel industry.
“We are, of course, following the 232 and are engaged because...
In brief: Final rule delay, Medline IPO, HME Appreciation Week, Philips earnings
November 5, 2025HME News Staff
WASHINGTON – A final rule with further details about CMS’s next round of the competitive bidding program (CBP) was not released last week, giving industry stakeholders more time to continue advocacy efforts, AAHomecare says.
The 2026 DMEPOS/Home Health Final Rule final rule was expected to be released on Oct. 31.
“Whether that delay is tied to the HME community’s all-out advocacy efforts on CBP provisions...
In brief: Amazon One Medical’s new partner, OIG’s new report, AASM’s new guidelines
October 31, 2025HME News Staff
AVON, Ohio – Amazon One Medical and Cleveland Clinic are expanding access to primary care in Northeast Ohio with the opening of the first of two planned offices in the region.
This first office in Avon, Ohio, will be followed with a second office in Shaker Heights, Ohio, by January 2026.
“Primary care helps patients lead healthier lives,” said Pooja Kamath, MD, medical director of Cleveland Offices, One Medical. “We can...